Matthew Puhl

About Matthew Puhl

Extensive experience managing the development of Clinical Study Protocols and conduct of clinical trials for small and mid-sized biotechnology and global biopharmaceutical companies in neuroscience, gut microbiome, and hematological oncology therapeutic areas- Success collaborating with cross-functional colleagues on multiple drug development programs encompassing all phases of clinical trials, as well as internal company initiatives (e.g, COVID medical task force, real-world data working group)- Supported efficacy strategy and slide development for two FDA-convened Psychopharmacologic Drugs Advisory Committee meetings and preparation for a planned meeting of the FDA Vaccines and Related Biological Products Advisory Committee- History of peer-reviewed publication of research findings in top-tiered scientific journals, and receipt of competitive grant awards from federal and private funding agencies- Seasoned presenter of scientific research findings in poster sessions and oral presentations at local, national, and international venues- Extensive experience in the interpretation of pre-clinical and clinical scientific research findings in the fields of psychiatry and translational neuroscience, with additional experience in the gut microbiome and hematological oncology fields

Experience

1. Clinical Scientist Lead, Psychiatry

   Bristol Myers Squibb

   Jan 2025 — Present · Cambridge, MA, US

Education

• University of Pittsburgh

  BS, Major: Psychology, Minor: Neuroscience

  1999 — 2003

• Pennsylvania State University College of Medicine

  PhD, Neuroscience

  2004 — 2010

Skills

• Teaching
• Life Sciences
• Scientific Writing
• Molecular Biology
• Neuroscience
• Western Blotting
• Research
• Animal Models
• Science
• Clinical Research
• Immunohistochemistry